Cardiac ablation and mapping
Cardiac ablation solutions clinical evidence
Explore the growing body of clinical evidence evaluating the safety and efficacy of our cardiac ablation technologies.
The Sphere-9™ catheter is supported by a robust body of clinical evidence. Stay up-to-date on the latest information supporting the dual-energy catheter.
SPHERE Per-AF was a randomized trial of patients with atrial fibrillation comparing the Sphere-9™ catheter with the Affera™ mapping and ablation system to the THERMOCOOL SMARTTOUCH™* SF catheter with the CARTO™* 3 system.
PULSED AF evaluated the safety and effectiveness of the PulseSelect™ PFA system for the treatment of patients with paroxysmal (PAF) or persistent (PsAF) atrial fibrillation.
View data from the clinical trial assessing initial rhythm control of paroxysmal AF with cryoballoon ablation versus antiarrhythmic drugs.
This trial assessed the use of the Freezor™ Xtra cardiac cryoablation catheter in treating atrioventricular nodal reentrant tachycardia (AVNRT).
Learn more about this randomized study on the effectiveness of the Arctic Front™ and Arctic Front Advance™ cardiac cryoablation catheters.
Discover information on this 1:1 randomized, noninferiority study comparing cryoballoon and radiofrequency ablation.
View information on this clinical trial assessing the safety and efficacy of the Medtronic cryoballoon in treating persistent AF patients.
TM* Third-party brands are trademarks of their respective owners.